BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17353905)

  • 1. DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.
    Takahashi M; Ozaki T; Takahashi A; Miyauchi M; Ono S; Takada N; Koda T; Todo S; Kamijo T; Nakagawara A
    Oncogene; 2007 Aug; 26(38):5669-73. PubMed ID: 17353905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors.
    Abel F; Sjöberg RM; Krona C; Nilsson S; Martinsson T
    Int J Oncol; 2004 Nov; 25(5):1297-302. PubMed ID: 15492818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over expression of inhibitor of caspase 3 activated deoxyribonuclease in human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy in vivo.
    Hara S; Miyake H; Arakawa S; Kamidono S; Hara I
    J Urol; 2001 Dec; 166(6):2491-4. PubMed ID: 11696816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA fragmentation factor 45 (DFF45) gene at 1p36.2 is homozygously deleted and encodes variant transcripts in neuroblastoma cell line.
    Yang HW; Chen YZ; Piao HY; Takita J; Soeda E; Hayashi Y
    Neoplasia; 2001; 3(2):165-9. PubMed ID: 11420752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
    Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
    Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of acetaminophen-induced apoptosis in cultured cells: roles of caspase-3, DNA fragmentation factor, and the Ca2+ and Mg2+ endonuclease DNAS1L3.
    Boulares AH; Ren T
    Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):19-29. PubMed ID: 14725611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin induces apoptosis in SH-SY5Y human neuroblastoma cell line.
    Cece R; Barajon I; Tredici G
    Anticancer Res; 1995; 15(3):777-82. PubMed ID: 7645958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal carcinoma cells undergo apoptosis without oligonucleosomal DNA fragmentation.
    Yamaguchi K; Uzzo R; Dulin N; Finke JH; Kolenko V
    Biochem Biophys Res Commun; 2004 Jun; 318(3):710-3. PubMed ID: 15144896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
    Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
    Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells.
    Zhang LJ; Hao YZ; Hu CS; Ye Y; Xie QP; Thorne RF; Hersey P; Zhang XD
    Anticancer Drugs; 2008 Feb; 19(2):159-66. PubMed ID: 18176112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T
    J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF; Xiao C; Li H; Yang SJ
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-specific expression of DNasegamma during B-cell development and its role in B-cell receptor-mediated apoptosis in WEHI-231 cells.
    Shiokawa D; Shika Y; Araki S; Sunaga S; Mizuta R; Kitamura D; Tanuma S
    Cell Death Differ; 2007 May; 14(5):992-1000. PubMed ID: 17218958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36.
    Chen YZ; Soeda E; Yang HW; Takita J; Chai L; Horii A; Inazawa J; Ohki M; Hayashi Y
    Genes Chromosomes Cancer; 2001 Aug; 31(4):326-32. PubMed ID: 11433523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
    Okamura M; Shimada J; Sakagami H
    Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus.
    Hu YW; Liu CY; Du CM; Zhang J; Wu WQ; Gu ZL
    J Ethnopharmacol; 2009 Jun; 123(2):293-301. PubMed ID: 19429375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
    David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
    Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.